TY - JOUR
T1 - Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
AU - Devi, Annu
AU - Pahuja, Isha
AU - Singh, Shashi Prakash
AU - Verma, Akanksha
AU - Bhattacharya, Debapriya
AU - Bhaskar, Ashima
AU - Dwivedi, Ved Prakash
AU - Das, Gobardhan
N1 - Funding Information:
We acknowledge funding support from the Department of Biotechnology, Government of India. We would also like to acknowledge funding support from the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India and ICGEB, New Delhi, India, and the Indian Council of Medical Research, Government of India.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to CSI and USTC.
PY - 2023/6
Y1 - 2023/6
N2 - Mesenchymal stem cells (MSCs) play diverse roles ranging from regeneration and wound healing to immune signaling. Recent investigations have indicated the crucial role of these multipotent stem cells in regulating various aspects of the immune system. MSCs express unique signaling molecules and secrete various soluble factors that play critical roles in modulating and shaping immune responses, and in some other cases, MSCs can also exert direct antimicrobial effects, thereby helping with the eradication of invading organisms. Recently, it has been demonstrated that MSCs are recruited at the periphery of the granuloma containing Mycobacterium tuberculosis and exert “Janus”-like functions by harboring pathogens and mediating host protective immune responses. This leads to the establishment of a dynamic balance between the host and the pathogen. MSCs function through various immunomodulatory factors such as nitric oxide (NO), IDO, and immunosuppressive cytokines. Recently, our group has shown that M.tb uses MSCs as a niche to evade host protective immune surveillance mechanisms and establish dormancy. MSCs also express a large number of ABC efflux pumps; therefore, dormant M.tb residing in MSCs are exposed to a suboptimal dose of drugs. Therefore, it is highly likely that drug resistance is coupled with dormancy and originates within MSCs. In this review, we discussed various immunomodulatory properties of MSCs, their interactions with important immune cells, and soluble factors. We also discussed the possible roles of MSCs in the outcome of multiple infections and in shaping the immune system, which may provide insight into therapeutic approaches using these cells in different infection models.
AB - Mesenchymal stem cells (MSCs) play diverse roles ranging from regeneration and wound healing to immune signaling. Recent investigations have indicated the crucial role of these multipotent stem cells in regulating various aspects of the immune system. MSCs express unique signaling molecules and secrete various soluble factors that play critical roles in modulating and shaping immune responses, and in some other cases, MSCs can also exert direct antimicrobial effects, thereby helping with the eradication of invading organisms. Recently, it has been demonstrated that MSCs are recruited at the periphery of the granuloma containing Mycobacterium tuberculosis and exert “Janus”-like functions by harboring pathogens and mediating host protective immune responses. This leads to the establishment of a dynamic balance between the host and the pathogen. MSCs function through various immunomodulatory factors such as nitric oxide (NO), IDO, and immunosuppressive cytokines. Recently, our group has shown that M.tb uses MSCs as a niche to evade host protective immune surveillance mechanisms and establish dormancy. MSCs also express a large number of ABC efflux pumps; therefore, dormant M.tb residing in MSCs are exposed to a suboptimal dose of drugs. Therefore, it is highly likely that drug resistance is coupled with dormancy and originates within MSCs. In this review, we discussed various immunomodulatory properties of MSCs, their interactions with important immune cells, and soluble factors. We also discussed the possible roles of MSCs in the outcome of multiple infections and in shaping the immune system, which may provide insight into therapeutic approaches using these cells in different infection models.
KW - Immunomodulation
KW - Immunotherapy
KW - Infectious Diseases
KW - Macrophages
KW - Mesenchymal Stem Cells (MSCs)
KW - T cells
KW - Tuberculosis
KW - Mycobacterium tuberculosis
KW - Cytokines
KW - Mesenchymal Stem Cells/physiology
KW - Humans
KW - Communicable Diseases
UR - http://www.scopus.com/inward/record.url?scp=85159263630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159263630&partnerID=8YFLogxK
U2 - 10.1038/s41423-023-01028-7
DO - 10.1038/s41423-023-01028-7
M3 - Review article
C2 - 37173422
AN - SCOPUS:85159263630
SN - 1672-7681
VL - 20
SP - 600
EP - 612
JO - Cellular and Molecular Immunology
JF - Cellular and Molecular Immunology
IS - 6
ER -